{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:24:47Z","timestamp":1790738687105,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    The mouse is a useful preclinical species for evaluating disease etiology due to the availability of a wide variety of genetically modified strains and the ability to perform disease-modifying manipulations. In order to establish an atrial filtration (AF) model in our laboratory, we profiled several commonly used murine AF models. We initially evaluated a pharmacological model of acute carbachol (CCh) treatment plus atrial burst pacing in C57BL\/6 mice. In an effort to observe micro-reentrant circuits indicative of authentic AF, we employed optical mapping imaging in isolated mouse hearts. While CCh reduced atrial refractoriness and increased atrial tachyarrhythmia vulnerability, the left atrial (LA) excitation patterns were rather regular without reentrant circuits or wavelets. Therefore, the atrial tachyarrhythmia resembled high frequency atrial flutter, not typical AF\n                    <jats:italic>per se<\/jats:italic>\n                    . We next examined both a chronic angiotensin II (Ang II) infusion model and the surgical model of transverse aortic constriction (TAC), which have both been reported to induce atrial and ventricular structural changes that serve as a substrates for micro-reentrant AF. Although we observed some extent of atrial remodeling such as fibrosis or enlarged LA diameter, burst pacing-induced atrial tachyarrhythmia vulnerability did not differ from control mice in either model. This again suggested that an AF-like pathophysiology is difficult to demonstrate in the mouse. To continue searching for a valid murine AF model, we studied mice with a cardiac-specific deficiency (KO) in liver kinase B1 (Cardiac-LKB1), which has been reported to exhibit spontaneous AF. Indeed, the electrocardiograms (ECG) of conscious Cardiac-LKB1 KO mice exhibited no P waves and had irregular RR intervals, which are characteristics of AF. Histological evaluation of Cardiac-LKB1 KO mice revealed dilated and fibrotic atria, again consistent with AF. However, atrial electrograms and optical mapping revealed that electrical activity was limited to the sino-atrial node area with no electrical conduction into the atrial myocardium beyond. Thus, Cardiac-LKB1 KO mice have severe atrial myopathy or atrial standstill, but not AF. In summary, the atrial tachyarrhythmias we observed in the four murine models were distinct from typical human AF, which often exhibits micro- or macro-reentrant atrial circuits. Our results suggest that the four murine AF models we examined may not reflect human AF well, and raise a cautionary note for use of those murine models to study AF.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0256512","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T13:31:47Z","timestamp":1641562307000},"page":"e0256512","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models"],"prefix":"10.1371","volume":"17","author":[{"given":"Fumin","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Tarnavski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj S.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjit K.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Deyneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon M.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K. P.","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gerard","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3589-445X","authenticated-orcid":true,"given":"Yuichiro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"11","key":"pone.0256512.ref001","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"F Rahman","year":"2014","journal-title":"Nature reviews Cardiology"},{"issue":"6","key":"pone.0256512.ref002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"PE Dilaveris","year":"2017","journal-title":"Clinical cardiology"},{"issue":"11","key":"pone.0256512.ref003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"P Kirchhof","year":"2016","journal-title":"Europace"},{"issue":"2","key":"pone.0256512.ref004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/europace\/eup328","article-title":"Animal models for atrial fibrillation: clinical insights and scientific opportunities","volume":"12","author":"K Nishida","year":"2010","journal-title":"Europace"},{"issue":"3","key":"pone.0256512.ref005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0008-6363(01)00264-4","article-title":"Induction of atrial tachycardia and fibrillation in the mouse heart","volume":"50","author":"H Wakimoto","year":"2001","journal-title":"Cardiovascular research"},{"issue":"8","key":"pone.0256512.ref006","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0735-1097(01)01304-3","article-title":"Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model","volume":"37","author":"P Kovoor","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"pone.0256512.ref007","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"V Rudolph","year":"2010","journal-title":"Nat Med"},{"issue":"4","key":"pone.0256512.ref008","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.109.146076","article-title":"Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury","volume":"55","author":"S Yagi","year":"2010","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"issue":"2","key":"pone.0256512.ref009","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCEP.111.000104","article-title":"Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation","volume":"6","author":"A Fukui","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"pone.0256512.ref010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2018.09.011","article-title":"Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation","volume":"124","author":"HJ Jansen","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"pone.0256512.ref011","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jjcc.2017.08.007","article-title":"Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation","volume":"71","author":"H Kondo","year":"2018","journal-title":"J Cardiol."},{"issue":"4","key":"pone.0256512.ref012","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1248\/bpb.b18-00363","article-title":"IL-1beta Plays an Important Role in Pressure Overload-Induced Atrial Fibrillation in Mice.","volume":"42","author":"N Matsushita","year":"2019","journal-title":"Biological & pharmaceutical bulletin"},{"issue":"2","key":"pone.0256512.ref013","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cvr\/cvy224","article-title":"Absence of natriuretic peptide clearance receptor attenuates TGF-beta1-induced selective atrial fibrosis and atrial fibrillation","volume":"115","author":"D Rahmutula","year":"2019","journal-title":"Cardiovascular research"},{"issue":"4","key":"pone.0256512.ref014","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cvr\/cvaa163","article-title":"Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts","volume":"117","author":"Y Zhang","year":"2021","journal-title":"Cardiovascular research"},{"issue":"1","key":"pone.0256512.ref015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCGENETICS.113.000259","article-title":"Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes","volume":"7","author":"Y Tao","year":"2014","journal-title":"Circ Cardiovasc Genet."},{"issue":"2","key":"pone.0256512.ref016","doi-asserted-by":"crossref","first-page":"H371","DOI":"10.1152\/ajpheart.00486.2018","article-title":"Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12","volume":"316","author":"Z Pan","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"pone.0256512.ref017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijcard.2011.10.057","article-title":"Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice","volume":"166","author":"P Kirchhof","year":"2013","journal-title":"Int J Cardiol"},{"issue":"354","key":"pone.0256512.ref018","doi-asserted-by":"crossref","first-page":"354ra115","DOI":"10.1126\/scitranslmed.aaf4891","article-title":"Pitx2 modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm","volume":"8","author":"RD Nadadur","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"pone.0256512.ref019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI84669","article-title":"Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice","volume":"126","author":"E Wan","year":"2016","journal-title":"J Clin Invest"},{"key":"pone.0256512.ref020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fphys.2012.00296","article-title":"An introduction to murine models of atrial fibrillation","volume":"3","author":"G Riley","year":"2012","journal-title":"Frontiers in physiology"},{"issue":"1","key":"pone.0256512.ref021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11427-017-9197-5","article-title":"AMPK and cardiac remodelling","volume":"61","author":"Y Feng","year":"2018","journal-title":"Science China Life sciences"},{"key":"pone.0256512.ref022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","article-title":"AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation","volume":"91","author":"EP Daskalopoulos","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"51","key":"pone.0256512.ref023","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","article-title":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction","volume":"284","author":"Y Ikeda","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0256512.ref024","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cvr\/cvv212","article-title":"LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation","volume":"108","author":"GE Kim","year":"2015","journal-title":"Cardiovascular research"},{"issue":"3","key":"pone.0256512.ref025","doi-asserted-by":"crossref","first-page":"e001733","DOI":"10.1161\/JAHA.114.001733","article-title":"LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process","volume":"4","author":"C Ozcan","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"pone.0256512.ref026","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15420\/aer.2014.3.2.90","article-title":"Mechanisms of Atrial Fibrillation\u2014Reentry, Rotors and Reality","volume":"3","author":"JW Waks","year":"2014","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"7324","key":"pone.0256512.ref027","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nature09571","article-title":"Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells","volume":"468","author":"D Nakada","year":"2010","journal-title":"Nature"},{"issue":"1","key":"pone.0256512.ref028","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.118.11813","article-title":"Immunoproteasome Subunit \u03b25i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice","volume":"73","author":"J Li","year":"2019","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"issue":"6","key":"pone.0256512.ref029","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.120.15016","article-title":"Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-\u03b21 (Transforming Growth Factor-\u03b21) and Interacting With Fibroblasts.","volume":"76","author":"Y Liu","year":"2020","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"key":"pone.0256512.ref030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/B978-0-12-417197-8.00013-4","article-title":"Constitutive activity of the acetylcholine-activated potassium current IK,ACh in cardiomyocytes","volume":"70","author":"N Voigt","year":"2014","journal-title":"Advances in pharmacology (San Diego, Calif)."},{"issue":"1","key":"pone.0256512.ref031","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41598-018-19719-x","article-title":"Expression and relevance of the G protein-gated K(+) channel in the mouse ventricle.","volume":"8","author":"A Anderson","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0256512.ref032","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fphar.2011.00064","article-title":"Targeting GIRK Channels for the Development of New Therapeutic Agents","volume":"2","author":"KB Walsh","year":"2011","journal-title":"Front Pharmacol"},{"issue":"2","key":"pone.0256512.ref033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0008-6363(01)00549-1","article-title":"Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin?","volume":"54","author":"AL Waldo","year":"2002","journal-title":"Cardiovascular research"},{"issue":"8","key":"pone.0256512.ref034","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.RES.85.8.742","article-title":"Shock-induced figure-of-eight reentry in the isolated rabbit heart","volume":"85","author":"I Banville","year":"1999","journal-title":"Circ Res"},{"key":"pone.0256512.ref035","doi-asserted-by":"crossref","first-page":"105804","DOI":"10.1016\/j.biocel.2020.105804","article-title":"Cardiac optical mapping\u2014State-of-the-art and future challenges","volume":"126","author":"C O\u2019Shea","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"pone.0256512.ref036","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1253\/circj.CJ-11-1301","article-title":"Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-beta1","volume":"76","author":"EK Choi","year":"2012","journal-title":"Circ J"},{"issue":"5","key":"pone.0256512.ref037","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCRESAHA.111.300158","article-title":"Rotors and the dynamics of cardiac fibrillation","volume":"112","author":"SV Pandit","year":"2013","journal-title":"Circ Res"},{"issue":"3","key":"pone.0256512.ref038","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11897-012-0102-z","article-title":"AMP-activated protein kinase in the control of cardiac metabolism and remodeling","volume":"9","author":"S Horman","year":"2012","journal-title":"Current heart failure reports"},{"key":"pone.0256512.ref039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2013.00081","article-title":"Connexin diversity in the heart: insights from transgenic mouse models","volume":"4","author":"S Verheule","year":"2013","journal-title":"Front Pharmacol"},{"issue":"5","key":"pone.0256512.ref040","first-page":"561","article-title":"An atrial-fibrillation-linked connexin40 mutant is retained in the endoplasmic reticulum and impairs the function of atrial gap-junction channels","volume":"7","author":"Y Sun","year":"2014","journal-title":"Disease models & mechanisms."},{"issue":"5","key":"pone.0256512.ref041","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1085\/jgp.201511475","article-title":"Altered conductance and permeability of Cx40 mutations associated with atrial fibrillation","volume":"146","author":"A Santa Cruz","year":"2015","journal-title":"The Journal of general physiology"},{"issue":"8","key":"pone.0256512.ref042","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.febslet.2014.01.010","article-title":"Atrial fibrillation-associated connexin40 mutants make hemichannels and synergistically form gap junction channels with novel properties","volume":"588","author":"D Patel","year":"2014","journal-title":"FEBS letters"},{"key":"pone.0256512.ref043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yjmcc.2013.09.008","article-title":"The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice","volume":"65","author":"I L\u00fcbkemeier","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"pone.0256512.ref044","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.hlc.2017.02.010","article-title":"Human Connexin40 Mutations Slow Conduction and Increase Propensity for Atrial Fibrillation","volume":"27","author":"A Kanthan","year":"2018","journal-title":"Heart, lung & circulation"},{"key":"pone.0256512.ref045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yjmcc.2014.06.010","article-title":"Degradation of a connexin40 mutant linked to atrial fibrillation is accelerated","volume":"74","author":"J Gemel","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"pone.0256512.ref046","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.amjcard.2017.02.002","article-title":"Impact of Left Ventricular Diastolic Property on Left Atrial Function from Simultaneous Left Atrial and Ventricular Three-Dimensional Echocardiographic Volume Measurement.","volume":"119","author":"M Yamano","year":"2017","journal-title":"Am J Cardiol"},{"key":"pone.0256512.ref047","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphys.2012.00345","article-title":"Cardiac electrophysiology in mice: a matter of size","volume":"3","author":"S Kaese","year":"2012","journal-title":"Frontiers in physiology"},{"issue":"7","key":"pone.0256512.ref048","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2012.05.022","article-title":"Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial","volume":"60","author":"SM Narayan","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"pone.0256512.ref049","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacep.2018.08.024","article-title":"Human Atrial Fibrillation Drivers Resolved With Integrated Functional and Structural Imaging to Benefit Clinical Mapping","volume":"4","author":"BJ Hansen","year":"2018","journal-title":"JACC Clinical electrophysiology."},{"issue":"6","key":"pone.0256512.ref050","doi-asserted-by":"crossref","first-page":"H2911","DOI":"10.1152\/ajpheart.01128.2005","article-title":"Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling","volume":"291","author":"Wilson EE Everett THt","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"pone.0256512.ref051","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1161\/01.RES.0000019783.88094.BA","article-title":"Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties","volume":"90","author":"J Kneller","year":"2002","journal-title":"Circ Res"},{"issue":"5","key":"pone.0256512.ref052","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/01.RES.71.5.1254","article-title":"Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium","volume":"71","author":"RB Schuessler","year":"1992","journal-title":"Circ Res"},{"issue":"9","key":"pone.0256512.ref053","doi-asserted-by":"crossref","first-page":"e72651","DOI":"10.1371\/journal.pone.0072651","article-title":"Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload.","volume":"8","author":"AM De Jong","year":"2013","journal-title":"PLoS One"},{"issue":"171","key":"pone.0256512.ref054","first-page":"1","article-title":"History of arrhythmias","author":"MJ Janse","year":"2006","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"pone.0256512.ref055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1924.4.2.215","article-title":"AURICULAR FIBRILLATION","volume":"4","author":"WE Garrey","year":"1924","journal-title":"Physiological Reviews"},{"issue":"2","key":"pone.0256512.ref056","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.85.2.174","article-title":"Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis","volume":"85","author":"D Vaidya","year":"1999","journal-title":"Circ Res"},{"issue":"35","key":"pone.0256512.ref057","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/eurheartj\/ehv233","article-title":"Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts","volume":"36","author":"BJ Hansen","year":"2015","journal-title":"Eur Heart J"},{"issue":"132","key":"pone.0256512.ref058","doi-asserted-by":"crossref","DOI":"10.3791\/56478","article-title":"Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping.","author":"K Ihara","year":"2018","journal-title":"J Vis Exp."},{"issue":"12","key":"pone.0256512.ref059","article-title":"Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias","volume":"9","author":"Y Bao","year":"2016","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"pone.0256512.ref060","article-title":"Artificially Created Reentry Circuit by Laser Irradiation Causes Atrial Tachycardia to Persist in Murine Atria","author":"S Horii","year":"2021","journal-title":"Circ J."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T13:32:30Z","timestamp":1641562350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256512"}},"subtitle":[],"editor":[{"given":"Elena G.","family":"Tolkacheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0256512","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.17.456655","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]}}}